Nanomedicines are medicinal products of at least one dimension in the nanoscale ranges – from 1nm to 100nm. They enhance the way in which medicines
The European Alliance for Access to Safe Medicines (EAASM) invites you to join its Parliament roundtable debate entitled “Preventing Medication errors across European hospitals to protect patient
Event summary of “Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process” held as a live webinar on 30th November 2021 10.00-11.30
Nanomedicines enhance the way that medicines target and reach areas of disease within the body, opening up new therapeutic options. They offer potential solutions for
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on “Nanomedicines and
At the 4th plenary session of the Medicrime Committee of the Parties (CoP) the Alliance for Safe Online Pharmacy in the EU (ASOP EU) was voted in and
Brussels – On 7 April 2021, the European Alliance for Access to Safe Medicines (EAASM)published its report ‘Patient Safety and the Implementation of the Falsified
EU Parliament virtual roundtable30 November 2020 Event summary On Monday 30th November, the European Alliance for Access to Safe medicines (EAASM) organised an online event
On behalf of the European Alliance for Access to Safe Medicines, you are kindly invited to join the upcoming virtual roundtable event on « Innovation in
Event summary of “Patient safety and the implementation of the Falsified Medicines Directive (FMD) in the hospital environment” held as a live webinar on 30th